VivaDiag SARS-CoV-2 Ag Rapid Test

VivaDiag SARS-CoV-2 Ag Quick Examine depends on immunoassay know-how for the speedy, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human oropharyngeal or nasopharyngeal swab specimens. The verify generates a finish end result inside 15 minutes determining people contaminated with COVID-19 quickly serving to to comprise the unfold of the virus.

The package deal includes all devices required along with swab, extraction tube, extraction decision and lateral circulation verify system. No specialised gear or personnel is required to utilize this verify. The assessments could also be carried out in any setting at any time by educated personnel, i.e for expert use solely

This lateral circulation Covid-19 Quick Antigen Examine Gear is for simple for educated personnel to handle delivering right outcomes rapidly using the oropharyngeal or nasopharyngeal swab specimen.

With the specimen collected insert the swab into the extraction tube filled with extraction decision. Having eradicated a testing system from the sealed pouch apply three drops of the reply and wait 15 minutes sooner than finding out the verify, a optimistic or detrimental end result’s clearly indicated.

This Covid-19 Quick Antigen Examine Gear has an basic accuracy of 98.79%, a specificity of 99.12% and a sensitivity of 90.90% providing full assurance of fast, right, reliable outcomes.

These assessments have to be used as part of a completely built-in COVID-19 approach, serving to find out these contaminated to chop again the unfold of the virus. VivaDiag™ SARS-CoV-2 Ag Quick Examine has ONLY been designed to behave as a supplementary verify for suspected situations of detrimental coronavirus nucleic acid detection or together with nucleic acid detection inside the evaluation of suspected situations. Outcomes from nucleocapsid protein antigen testing should not be used as the one actual basis to diagnose or exclude SARS-CoV-2 (COVID-19) an an infection or to inform an an infection standing.

Principle and meant use

Immupass VivaDiag SARS-CoV-2 Ag Quick Examine is supposed for medical laboratories and healthcare expert use only for point-of-care testing. Not for at-home testing.

Immupass VivaDiag™ SARS-CoV-2 Ag Quick Examine depends on immunoassay know-how. Each verify system has one line of anti-SARS coronavirus monoclonal antibody on the detection line (T line) and one line of anti-mouse IgG polyclonal antibody on the usual administration line (C line).

When extracted specimen is added to the specimen correctly, it ought to react with the labeled antibody to kind a complicated, the mixture then migrates by the use of the membrane by capillary movement and interacts with the coated anti-SARS coronavirus monoclonal antibody on the detection line. If the specimen includes SARS-CoV-2 antigen, the detection line will appear purplish-red indicating the SARS-CoV-2 antigen is optimistic. In some other case, the verify finish end result shall be detrimental. The verify system moreover includes a high quality administration line C which ought to look purplish-red for all professional assessments. If the usual administration line C does not appear, the verify finish end result shall be invalid even when the detection line appears.

Composition

Each verify package deal includes: 25 verify devices, 25 extraction tubes (prefilled with extraction decision 300 μL / tube), filtered nozzles, 1 tube stand, 25 sterile swabs and 1 bundle insert.

Provides required nonetheless couldn’t equipped: timer.

Specification

SARS-CoV-2 Rapid Antigen Test Nasal
9901-NCOV-03G	Roche Diagnostics	25 Tests/Kit	EUR 94
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva)
IOV87952	INVBIO	20T/kit	EUR 39
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications.

Ag rapid CDV Ag Test Kit
RG11-03	Bionote	1 box	EUR 138.2
Description: Please check the datasheet of Ag rapid CDV Ag Test Kit before using the test.

Ag Rapid AIV Ag Test Kit
RG15-01	Bionote	1 box/30 tests	EUR 267
Description: Please check the datasheet of Ag Rapid AIV Ag Test Kit before using the test.

Ag Rapid H5AIV Ag test kit
RG15-05	Bionote	1 box	EUR 463
Description: Please check the datasheet of Ag Rapid H5AIV Ag test kit before using the test.

Rapid PED Ag Test Kit
RG14-01	Bionote	1 box	EUR 159.9
Description: Please check the datasheet of Rapid PED Ag Test Kit before using the test.

Ag Rapid CIRD-3 Ag Test Kit
RG11-09	Bionote	1 box	EUR 123.64
Description: Please check the datasheet of Ag Rapid CIRD-3 Ag Test Kit before using the test.

Rapid TGE/PED Ag Test Kit
RG14-03	Bionote	1 box	EUR 240.85
Description: Please check the datasheet of Rapid TGE/PED Ag Test Kit before using the test.

Dynamiker Monkeypox Virus Ag Rapid Test
DNK-2114-1	Dynamiker Biotechnology	20 tests	EUR 585
Description: The product is a lateral flow chromatographic immunoassay for the qualitative detection of monkeypox virus antigen in human whole blood, serum, plasma or rash exuudate. The kit is intended for professional use only.

Ag Rapid FMD NSP Ab Test Kit
RB28-02	Bionote	1 box	EUR 108.52
Description: Please check the datasheet of Ag Rapid FMD NSP Ab Test Kit before using the test.

Bionote Rapid AIV Ag_NDV Ag Test Kit
RG15-09	Bionote	1 box	EUR 164.52
Description: Please check the datasheet of Bionote Rapid AIV Ag_NDV Ag Test Kit before using the test.

Ag Rapid Bov. TB Ab Test Kit
RB23-02	Bionote	1 box	EUR 145
Description: Please check the datasheet of Ag Rapid Bov. TB Ab Test Kit before using the test.

Anigen Rapid FIV Ab/FeLV Ag Test Kit
RC12-04-DD	Bionote	10 tests/Kit	EUR 152.2
Description: Please check the datasheet of Anigen Rapid FIV Ab/FeLV Ag Test Kit before using the test.

Panbio™ COVID-19 Ag Rapid Test Device
41FK10	Abbott	25 Tests/Kit	EUR 96

Panbio™ COVID-19 Ag Rapid Test Device (Nasal)
41FK11	Abbott	25 Tests/Kit	EUR 95
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19

Anti-SARS-CoV-2 Neutralization Antibody Test Kit (Colloidal gold immunoassay)
CP04010	UnScience	25T/kit	Ask for price
Description: The Anti-SARS-CoV-2 Neutralization Antibody Test Kit (Serum/Plasma/Whole blood) is a qualitative membrane-based immunoassay for the detection of SARS-CoV-2 neutralizing antibodies in serum, plasma and whole blood. The sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 neutralizing antibodies in the sample combined with the colloidal gold-labeled SARS-CoV-2 spike protein(SP), then spread to the test area. It is captured by coated SP subunit RBDNTD-CTD, to form a complex and gather in the test area (T line). The quality control area is coated with mouse anti-chicken IgY, and the colloidal goldlabeled chicken IgY is captureed to form a complex and aggregate in hte quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample need to be tested again.

SARS CoV-2 PCR kit
PCR-H731-48R	Bioingentech	48T	EUR 823

SARS CoV-2 PCR kit
PCR-H731-96R	Bioingentech	96T	EUR 1113

SARS-CoV-2 Spike Peptide
9083P	ProSci	0.05 mg	EUR 196.25
Description: (NT) SARS-CoV-2 Spike peptide

SARS-CoV-2 Spike Peptide
9087P	ProSci	0.05 mg	EUR 196.25
Description: (CT) SARS-CoV-2 Spike RBD peptide

SARS-CoV-2 Spike Peptide
9091P	ProSci	0.05 mg	EUR 196.25
Description: (IN) SARS-CoV-2 Spike peptide

SARS-CoV-2 Spike Peptide
9095P	ProSci	0.05 mg	EUR 196.25
Description: (IN) SARS-CoV-2 Spike peptide

SARS-CoV-2 Nucleocapsid Peptide
9099P	ProSci	0.05 mg	EUR 196.25
Description: (IN) SARS-CoV-2 Nucleocapsid peptide

SARS-CoV-2 Nucleocapsid Peptide
9103P	ProSci	0.05 mg	EUR 196.25
Description: (CT) SARS-CoV-2 Nucleocapsid peptide

Anti-SARS-CoV-2 Antibody
A2061-50	Biovision	50 µg	EUR 480